257 related articles for article (PubMed ID: 16710536)
1. Access to AIDS medicines stumbles on trade rules.
Wise J
Bull World Health Organ; 2006 May; 84(5):342-4. PubMed ID: 16710536
[No Abstract] [Full Text] [Related]
2. New frontier of AIDS activism: international trade rules and global access to medicines. Interview by John S. James.
Sawyer E
AIDS Treat News; 1999 Apr; (No 317):1, 5-8. PubMed ID: 11366992
[TBL] [Abstract][Full Text] [Related]
3. WTO accepts rules limiting medicine exports to poor countries.
James JS
AIDS Treat News; 2003 Sep; (394):2-6. PubMed ID: 14669728
[TBL] [Abstract][Full Text] [Related]
4. Essential AIDS medications in India.
Thomas J
Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
[No Abstract] [Full Text] [Related]
5. Implications of bilateral free trade agreements on access to medicines.
Correa CM
Bull World Health Organ; 2006 May; 84(5):399-404. PubMed ID: 16710551
[TBL] [Abstract][Full Text] [Related]
6. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
7. U.S. blocks trade agreement on generic drug access in poor countries.
James JS
AIDS Treat News; 2002 Dec; (386):4-6. PubMed ID: 12569874
[TBL] [Abstract][Full Text] [Related]
8. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
Cohen-Kohler JC; Forman L; Lipkus N
Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
[TBL] [Abstract][Full Text] [Related]
9. Finding flaws: the limitations of compulsory licensing for improving access to medicines--an international comparison.
Ng E; Kohler JC
Health Law J; 2008; 16():143-72. PubMed ID: 19536980
[No Abstract] [Full Text] [Related]
10. Essential drugs in the new international economic environment.
Velásquez G; Boulet P
Bull World Health Organ; 1999; 77(3):288-92. PubMed ID: 10212525
[TBL] [Abstract][Full Text] [Related]
11. The morally uncomfortable global drug gap.
Cohen-Kohler JC
Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
[TBL] [Abstract][Full Text] [Related]
12. Trade agreements, intellectual property, and the role of the World Bank in improving access to medicines in developing countries.
Rovira J
Yale J Health Policy Law Ethics; 2004; 4(2):401-13. PubMed ID: 15536921
[No Abstract] [Full Text] [Related]
13. Access to essential drugs.
Dev World Bioeth; 2001 Nov; 1(2):89-92. PubMed ID: 12870517
[No Abstract] [Full Text] [Related]
14. Inequalities in health: access to treatment for HIV/AIDS.
Giuliano M; Vella S
Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
[TBL] [Abstract][Full Text] [Related]
15. Improving access to essential drugs for people living with HIV/AIDS.
Balasubramaniam K
Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335
[No Abstract] [Full Text] [Related]
16. CAFTA will harm HIV care, according to critics. Final agreement helps drug companies, they say.
AIDS Alert; 2004 Feb; 19(2):17-8. PubMed ID: 15011625
[TBL] [Abstract][Full Text] [Related]
17. Emerging consensus in HIV/AIDS, malaria, tuberculosis, and access to essential medicines.
Ruxin J; Paluzzi JE; Wilson PA; Tozan Yi; Kruk M; Teklehaimanot A
Lancet; 2005 Feb 12-18; 365(9459):618-21. PubMed ID: 15708108
[No Abstract] [Full Text] [Related]
18. U.S., Switzerland oppose developing-country proposal on access to medicines.
James JS
AIDS Treat News; 2001 Sep; (371):5. PubMed ID: 11668978
[No Abstract] [Full Text] [Related]
19. U.S. is lone holdout on drug access vote.
AIDS Policy Law; 2003 Jan; 18(1):1. PubMed ID: 12569860
[No Abstract] [Full Text] [Related]
20. Poor countries should use flexibility in global trade agreement to improve access to antiretrovirals, says report.
Zarocostas J
BMJ; 2011 Mar; 342():d1677. PubMed ID: 21411492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
